{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:18:00Z","timestamp":1790662680433,"version":"4.1.0"},"reference-count":32,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1179\/joc.2009.21.3.261","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T13:05:58Z","timestamp":1389272758000},"page":"261-266","source":"Crossref","is-referenced-by-count":10,"title":["Comparative<i>In Vitro<\/i>Activity of Tigecycline and Nine Other Antibiotics Against Gram-Negative Bacterial Isolates, Including ESBL-Producing Strains"],"prefix":"10.1080","volume":"21","author":[{"given":"W.Y.","family":"Jamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Al Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Khodakhast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.O.","family":"Rotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464010-00005"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.08.011"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh125"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.40.9.2226","volume":"40","author":"Bergeron J","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.972-978.2003"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.791-793.2005"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01621.x"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm058"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409573200"},{"key":"CIT0010","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial susceptibility Testing: Seventeenth Informational supplement, M 100-S17. CLSI 2007, Wayne, PA, USA"},{"key":"CIT0011","unstructured":"Weyth Pharmaceutical Inc. Tygacil Product Insert. Philadelphia, PA, USA."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1212-1217.2002"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1086\/499406"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1159\/000086930"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2008.20.4.445"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1086\/429822"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2005.11.330"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm310"},{"issue":"36","key":"CIT0021","first-page":"807","volume":"36","author":"Tan T-Y","year":"2007","journal-title":"Susceptibility of multi-drug resistant Gram-negative bacilli in Singapore to tigecycline as tested by agar dilution. Ann Acad Med Singapore"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.04.023"},{"key":"CIT0023","unstructured":"Rotimi V, Jamal W, Salama MI, AL-Din K, Dehrab N. Role of tigecycline in the control of carbapenem-resistant Acineto-bacter baumannii infections in an Intensive Care Unit, Kuwait, Abstract # P795, Proceedings of the 18th ECCMID, Barcelona, 2008, page 92"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4479-4481.2004"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00116-06"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm018"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl441"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1999.11.5.349"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1179\/joc.2003.15.2.113","volume":"15","author":"Phillips OA","year":"2003","journal-title":"J Chemother"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki197"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01435-06"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.1034-1036.2004"},{"key":"CIT0034","first-page":"173","volume":"52","author":"Bouchillon SK","year":"2005","journal-title":"In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program 2004): Diagn Microbiol Infect Dis"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki291"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:49:15Z","timestamp":1565052555000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2009.21.3.261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1179\/joc.2009.21.3.261"],"URL":"https:\/\/doi.org\/10.1179\/joc.2009.21.3.261","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}